A patient with a history of metastatic breast cancer presents with decreased breath sounds and dullness to percussion over the right lower lung field. Imaging reveals a pleural effusion and mediastinal lymphadenopathy. Which nursing intervention is most appropriate to address the patient's current respiratory symptoms?

C) Prepare the patient for a thoracentesis procedure to relieve respiratory distress.

A) Encourage the patient to perform deep-breathing exercises and use an incentive spirometer.

B) Position the patient in a high Fowler's position to facilitate breathing.

C) Prepare the patient for a thoracentesis procedure to relieve respiratory distress.

D) Administer supplemental oxygen via nasal cannula at 2 liters per minute.

A patient with a history of breast cancer presents with decreased breath sounds and dullness to percussion over the right lower lung field, mild hypoxemia, and new onset of dysphagia. Imaging reveals a right pleural effusion, nodular opacities in the lung parenchyma, and mediastinal lymphadenopathy. What is the nurse's priority intervention to address the patient's respiratory symptoms?

C) Prepare the patient for thoracentesis to relieve the pleural effusion.

A) Administer supplemental oxygen to improve oxygen saturation.

B) Position the patient in high Fowler's position to facilitate breathing.

C) Prepare the patient for thoracentesis to relieve the pleural effusion.

D) Encourage deep breathing and coughing exercises to clear lung secretions.

A patient with recurrent pleural effusion and mild anemia is starting a new systemic chemotherapy regimen. Which nursing intervention is most appropriate to address the patient's fatigue and optimize her energy levels?

A) Encourage the patient to engage in light physical activity such as short walks, as tolerated, throughout the day.

B) Advise the patient to increase her fluid intake to at least 3 liters per day to help manage symptoms.

C) Suggest the patient rest for long periods during the day to conserve energy for essential activities.

D) Recommend a high-protein diet with frequent small meals to enhance energy levels and support overall health.

A patient with a history of metastatic cancer is experiencing increased fatigue, a persistent cough, and laboratory findings of mild anemia and elevated liver enzymes. Given these new developments, which nursing intervention is most appropriate to address the patient's anemia and optimize energy levels?

C) Suggest small, frequent meals rich in iron and protein to support nutritional needs and energy levels.

A) Encourage the patient to increase physical activity to build stamina and reduce fatigue.

B) Coordinate with the healthcare team to initiate iron supplementation therapy to improve hemoglobin levels.

C) Suggest small, frequent meals rich in iron and protein to support nutritional needs and energy levels.

D) Advise the patient to limit fluid intake to prevent further pleural effusion reaccumulation.

A patient undergoing chemotherapy has developed mild jaundice, elevated liver enzymes, and decreased hemoglobin levels. As a nurse, what is the most appropriate intervention to prioritize in managing this patient’s symptoms?

A) Administering prescribed hepatoprotective agents

B) Increasing the frequency of vital signs monitoring

C) Initiating a high-protein diet to support liver function

D) Scheduling frequent rest periods to manage fatigue

A patient undergoing a new chemotherapy regimen for cancer treatment presents with increased liver enzymes, jaundice, and declining hemoglobin levels. Which nursing intervention is the most appropriate to address the patient's current condition?

A) Administer the prescribed hepatoprotective agents and monitor liver function tests regularly.

B) Increase the frequency of chemotherapy administration to enhance cancer control.

C) Encourage increased fluid intake to flush out the chemotherapy drugs.

D) Discontinue the chemotherapy treatment immediately and inform the healthcare provider.

A patient undergoing chemotherapy for liver cancer is experiencing mild tachycardia and persistent elevated bilirubin levels. Given these clinical findings, which nursing intervention is most appropriate to prioritize in the care plan?

A) Increase the frequency of vital signs monitoring to detect early signs of deterioration.

B) Administer antiemetics before meals to prevent nausea and ensure adequate nutrition.

C) Encourage the patient to rest frequently to manage fatigue associated with anemia.

D) Collaborate with the healthcare team to evaluate and adjust the dose of erythropoietin-stimulating agents.

A patient undergoing chemotherapy for cancer treatment is experiencing mild tachycardia and elevated bilirubin levels. Which nursing intervention should be prioritized to address these findings?

C) Collaborate with the dietitian to ensure adequate nutritional support.

A) Increase the frequency of monitoring vital signs to every 2 hours.

B) Administer prescribed antiemetics before meals to manage nausea.

C) Collaborate with the dietitian to ensure adequate nutritional support.

D) Encourage rest periods and limit physical activity to manage anemia-related fatigue.

A patient with liver dysfunction and cancer has developed ascites and is experiencing mild abdominal discomfort and shortness of breath. A paracentesis revealed a SAAG of 1.3 g/dL, indicating portal hypertension. Which nursing intervention is most appropriate to help manage the patient's condition and prevent complications?

B) Educate the patient on the importance of a low-sodium diet to reduce fluid accumulation.

A) Encourage the patient to drink 3 liters of water daily to maintain hydration.

B) Educate the patient on the importance of a low-sodium diet to reduce fluid accumulation.

C) Advise the patient to increase physical activity to promote fluid mobilization.

D) Recommend the use of compression garments to decrease abdominal girth.

A patient with liver dysfunction and a diagnosis of cancer presents with increased abdominal girth, shortness of breath, and a confirmed diagnosis of ascites due to portal hypertension. Which nursing intervention is most appropriate to prioritize in managing this patient's condition?

A) Administer prescribed diuretics and monitor for electrolyte imbalances.

B) Restrict fluid intake to prevent further ascitic fluid accumulation.

C) Encourage high-protein diet to promote oncotic pressure.

D) Position the patient in a Trendelenburg position to facilitate fluid drainage.

cancer - Nursing Case Study

Pathophysiology

• Primary mechanism: Uncontrolled cell proliferation - Cancer arises from mutations in genes regulating cell growth and division. These mutations lead to the continuous and unchecked multiplication of cells, forming tumors.

• Secondary mechanism: Evasion of apoptosis - Cancer cells develop the ability to avoid programmed cell death, allowing damaged or abnormal cells to survive longer than normal, contributing to tumor growth and resistance to treatment.

• Key complication: Metastasis - Cancer cells can invade nearby tissues and spread to distant body parts through the bloodstream or lymphatic system, complicating treatment and significantly impacting prognosis.

Patient Profile

Demographics:

58-year-old female, school teacher

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Breast cancer (Stage II) diagnosed six months ago

• Current medications: Metformin, Lisinopril, Tamoxifen

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Shortness of breath and persistent cough

• Key symptoms: Fatigue, weight loss, night sweats, occasional chest pain

• Vital signs: Blood pressure 145/90 mmHg, heart rate 102 bpm, respiratory rate 24 breaths per minute, temperature 99.5°F

Section 1

As the healthcare team conducted an initial assessment, further investigation into the patient's symptoms revealed some concerning findings. On physical examination, decreased breath sounds and dullness to percussion were noted over the right lower lung field, suggesting a possible pleural effusion or pulmonary involvement. The patient's oxygen saturation was measured at 91% on room air, indicating mild hypoxemia. In addition to her respiratory symptoms, the patient reported new onset of mild dysphagia, which she described as a sensation of a lump in her throat when swallowing, raising suspicion for potential esophageal or mediastinal involvement.

Clinical reasoning directed the team to order a chest X-ray and a CT scan of the thorax, which revealed a pleural effusion on the right side and several nodular opacities in the lung parenchyma, consistent with metastatic spread of her breast cancer. The imaging also showed mediastinal lymphadenopathy, which could be compressing the esophagus and contributing to her dysphagia. Given these findings, the decision was made to proceed with a thoracentesis to relieve her respiratory symptoms and obtain fluid for cytological analysis, confirming the metastatic nature of her disease.

As the patient awaits further intervention, the team must consider the implications of these new developments on her treatment plan. The presence of metastasis suggests a need for a potential change in her therapeutic strategy, possibly involving systemic chemotherapy or targeted therapies. Monitoring her respiratory status and managing her symptoms remain a priority, as does coordinating with oncology to ensure a comprehensive approach to her evolving condition. This situation demands careful clinical reasoning to balance symptom management with the aggressive treatment needed to address the cancer's progression.

Section 2

As the team continued to monitor the patient, her respiratory status showed signs of improvement following the thoracentesis, with oxygen saturation levels rising to 94% on room air. However, during a routine follow-up, the patient reported increased fatigue and a persistent cough. A repeat chest X-ray was performed, which suggested reaccumulation of the pleural effusion, indicating the need for ongoing management. In addition, laboratory results revealed a mild anemia with a hemoglobin level of 10 g/dL, and elevated liver enzymes were noted, raising concerns about potential hepatic involvement or side effects from her previous treatments.

In light of these new complications, the medical team convened to reassess the patient’s therapeutic regimen. The presence of anemia and liver enzyme elevation prompted further investigations, including a liver ultrasound and a complete blood count. The ultrasound showed mild hepatomegaly with scattered hypoechoic lesions, suspect for additional metastases. The decision was made to initiate a new systemic chemotherapy regimen, tailored to address both the pulmonary and potential hepatic metastases, while also considering supportive care measures to manage anemia and optimize the patient's energy levels.

The patient’s ongoing symptoms and diagnostic findings necessitated a multidisciplinary approach to care. The oncology team coordinated with a nutritionist to address potential dietary deficiencies contributing to her anemia, while a palliative care specialist was consulted to assist with symptom management and ensure the patient’s quality of life remained a central focus. These steps highlighted the need for continued vigilance in monitoring her response to treatment and adjusting her care plan as her condition evolved, setting the stage for the next phase of her cancer journey.

Section 3

As the patient embarked on the new chemotherapy regimen, the healthcare team closely monitored her response to the treatment and her overall condition. Within two weeks, the patient exhibited a partial response to the new chemotherapy, as evidenced by a decrease in the size of the pleural effusion on follow-up imaging and a modest improvement in her respiratory symptoms. However, despite these positive developments, the patient reported persistent fatigue and a new onset of mild jaundice, which raised concerns about the evolving status of her liver function.

Routine laboratory tests revealed a further decline in hemoglobin levels to 9.5 g/dL, alongside a marked increase in liver enzymes, with alanine transaminase (ALT) rising to 150 U/L and aspartate transaminase (AST) climbing to 130 U/L. Additionally, bilirubin levels were noted to be elevated at 2.5 mg/dL, corroborating the clinical signs of jaundice. These findings suggested worsening hepatic involvement, potentially exacerbated by the chemotherapy regimen, necessitating a reevaluation of her treatment plan.

In response to these developments, the oncology team collaborated with hepatology specialists to explore potential adjustments to the chemotherapy protocol that might mitigate liver toxicity while maintaining efficacy against the cancer. A decision was made to introduce hepatoprotective agents and consider dose modification of the chemotherapy drugs. Meanwhile, the supportive care team intensified efforts to manage the patient's anemia and fatigue through nutritional interventions and erythropoietin-stimulating agents. These combined efforts aimed to stabilize the patient's condition and enhance her quality of life, as the team prepared for the next phase of her treatment journey.

Section 4

As the oncology and hepatology teams implemented the adjusted treatment plan, the patient's condition was monitored closely over the subsequent week. During this period, the patient was assessed daily for any changes in her clinical status. Initial assessment findings indicated a slight improvement in her energy levels, as reported by the patient feeling less fatigued during the day. Vital signs remained stable, with the exception of a mild tachycardia, noted at 102 beats per minute, which was attributed to her anemia. Blood pressure was recorded as 118/76 mmHg, and her temperature remained normothermic at 98.4°F.

The introduction of hepatoprotective agents appeared to have a positive impact on her liver function tests. Follow-up laboratory results showed a modest decrease in liver enzyme levels, with ALT reduced to 120 U/L and AST down to 110 U/L. Bilirubin levels, however, remained elevated at 2.4 mg/dL, suggesting persistent but non-worsening hepatic dysfunction. Hemoglobin levels showed a slight increase to 9.8 g/dL, indicating a partial response to erythropoietin-stimulating agents and nutritional support. Despite these improvements, the patient reported intermittent episodes of nausea, prompting a review of her antiemetic regimen to ensure optimal symptom control.

The patient's overall response to the interventions was cautiously optimistic, yet the healthcare team remained vigilant for any potential complications. The focus continued to be on balancing the efficacy of the chemotherapy with the management of side effects, ensuring the patient's quality of life was maintained as she progressed through her treatment. The team prepared for further imaging and laboratory tests to guide the ongoing adjustments to her care plan, remaining ready to address any new challenges that might arise in her cancer treatment journey.

Section 5

As the week progressed, the patient began to experience new symptoms that prompted further investigation by the healthcare team. She developed mild abdominal discomfort and noticed a gradual increase in abdominal girth, accompanied by occasional shortness of breath, particularly when lying flat. These symptoms raised the suspicion of ascites, a potential complication given her underlying liver dysfunction and cancer diagnosis. A physical examination confirmed the presence of shifting dullness on percussion, and an abdominal ultrasound revealed moderate ascitic fluid accumulation. The oncology and hepatology teams collaborated to determine the etiology, considering both malignant ascites and portal hypertension as possible contributors.

To better understand the underlying cause and guide treatment decisions, a paracentesis was performed. Analysis of the ascitic fluid revealed a serum-ascites albumin gradient (SAAG) of 1.3 g/dL, consistent with portal hypertension. This finding, combined with the imaging results, suggested an increased pressure in the portal venous system, likely exacerbated by her liver condition. The patient's vital signs remained stable, with blood pressure at 116/74 mmHg and heart rate at 98 beats per minute, though she reported a persistent sensation of fullness and discomfort.

In response to these developments, the healthcare team adjusted the patient's treatment plan to include diuretics to manage the fluid overload and alleviate symptoms. Additionally, they intensified monitoring for signs of electrolyte imbalances and renal function deterioration, recognizing the delicate balance required in managing ascites without compromising kidney health. The patient was educated about dietary sodium restrictions to support fluid management and encouraged to report any worsening symptoms promptly. This new complication underscored the need for meticulous coordination between oncology and hepatology care to optimize her treatment and maintain her quality of life. As the team prepared for ongoing assessment and follow-up, they remained vigilant for any further changes in her clinical status.